Quality of Life of Patients Treated for Abdominal Aortic Aneurysm: Open Surgery and Endoprosthesis

• Published in: Journal of clinical medicine Vol. 11; no. 8; p. 2195
• Main Authors: Barrena-Blázquez, Silvestra, Díez-Alonso, Manuel, Riera Del Moral, Luis Felipe, Sanchez Coll, Salvador, Alvarez-Mon, Melchor, Ortega, Miguel A, Ruiz Grande, Fernando
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14-04-2022; MDPI
• Subjects: Abdomen; Aneurysms; Aortic aneurysms; Clinical medicine; Hospitals; Mental health; Morbidity; Morphology; Mortality; Patients; Prostheses; Quality of life; Questionnaires; Statistical analysis; Surgery; EVAR; health-related quality of life; open abdominal repair; abdominal aortic aneurysm; SF-36 questionnaire
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11082195

To determine the degree of long-term health-related quality of life (HRQoL) of patients undergoing surgery for abdominal aortic aneurysm (AAA) and to analyze the results according to the type of treatment, namely, open abdominal repair (OAR) or endoprosthesis (EVAR).
This was a prospective cross-sectional observational study. Patients receiving intervention for AAA between January 2013 and December 2020 were included. The Spanish version of the SF-36 questionnaire was used. A single survey was performed on all patients, and the time elapsed since the intervention was recorded.
On all health scales and in the two groups of patients, the highest scores were recorded at six months postoperatively. At that time, the EVAR and OAR groups had similar values. Between 13 and 16 months postoperatively, EVAR patients presented a transient but significant decrease in their scores for physical function (
= 0.016), vitality (
= 0.035) and social function (
= 0.041). From that moment, there were progressive decreases in the scores of the two groups of patients on all the scales of the SF-36 questionnaire, although this trend was less pronounced in the OAR group. At 60 months after the intervention, the latter group showed significantly higher values than EVAR for physical function (
= 0.01), vitality (
= 0.032) and mental health (
= 0.029). Additionally, at 60 months after the intervention, the Sum of the psychological component (MCS) and Sum of the physical component (PCS) scores were significantly higher in the OAR group (
= 0.040 and
= 0.039, respectively).
In the short term, patients treated for AAA by EVAR or OAR showed similar results on the SF-36 questionnaire. In the long term, patients treated by EVAR had lower scores on the physical function, vitality and mental health scales.